端粒长度作为骨质疏松症预测生物标志物 (综述)
Fotios Kakridonis1, Spyros G Pneumatikos2,3, Elena Vakonaki4
15th Department of Orthopaedics, KAT Attica General Hospital, 14561 Athens, Greece.
Biomedical reports
|October 26, 2023
概括
端粒缩短,染色体末端的缩短,可以作为骨质疏松症的生物标志物. 虽然证据是混合的,但一些研究表明,短端粒与这种骨疾病之间存在联系.
科学领域:
- 遗传学 遗传学 是一个
- 老年学是一门学科.
- 整形外科 整形外科 整形外科
背景情况:
- 端粒可以保护染色体末端免受DNA损伤.
- 端粒缩短与晚年有关.
- 衰老是骨质疏松症的一个危险因素.
研究的目的:
- 审查端粒缩短作为骨质疏松症发病的生物标志物的潜力.
- 评估端粒长度与骨质疏松症之间的关联.
主要方法:
- 科学文献的系统审查.
- 搜索的数据库:PubMed/NCBI,Cochrane,Scopus,Embase,Google Scholar. 这些数据库中的数据库包括:
- 包括人体研究:随机/非随机受控试验,病例系列.
主要成果:
- 包括11项涉及人类的研究.
- 六项研究表明,端粒长度与骨质疏松症之间存在微弱的关联.
- 五项研究发现端粒长度与骨质疏松症之间没有关联.
结论:
- 端粒缩短显示出作为骨质疏松症生物标志物的潜力.
- 它可以单独或组合使用,用于跟踪骨质疏松症的发病和进展.
相关概念视频
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Telomeres and Telomerase
23.4K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.4K
Replication in Eukaryotes
170.9K
Overview
170.9K
Bone Disorders
3.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.6K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K


